MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Resolving missing data from the MDS-UPDRS: implications for telemedicine

    S. Luo, C. Goetz, D. Choi, S. Aggarwal, T. Mestre, G. Stebbins (Durham, USA)

    Objective: The aim of this study was to determine imputation accuracy for total-sum and item-specific MDS-UPDRS Part III (Motor Examination) scores in remote administration. Background:…
  • 2023 International Congress

    Cost-effectiveness of Lee Silverman Voice Treatment LOUD (LSVT®) versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease: An economic evaluation alongside the PD COMM trial

    C. Clarke, Z. Abdali, S. Jowett, C. Rick, M. Brady, R. Woolley, C. Burton, S. Patel, P. Masterson-Algar, A. Nicoll, C. Smith, N. Ives, G. Beaton, S. Dickson, R. Ottridge, H. Nankervis, C. Sackley (Birmingham, United Kingdom)

    Objective: We evaluated the cost effectiveness of two speech and language therapy techniques compared with no therapy in people with Parkinson's disease who have problems…
  • 2023 International Congress

    MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease

    K. Pillai, S. Joshua, A. Nair, D. Panikar, M. Chacko, A. Thalakkattu, A. Avarachan, H. Prakash, A. Kishore (Kochi, India)

    Objective: To test whether the length of the subthalamic nucleus (STN) in microelectrode recording (MER) can predict the 6-month motor and non-motor outcomes of DBS…
  • 2023 International Congress

    Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

    S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

    Objective: To provide a reference of individual Parkinson’s disease (PD) progression by assessing multimodal milestones over 10 years (y) in patients of the DeNoPa cohort.…
  • 2023 International Congress

    Parkinsonism in sjogren disease

    G. Wechtati, H. Derbali, I. Bedoui, M. Yedaes, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Ben Arous, Tunisia)

    Objective: explain the cause of parkinsonism in Sjogren's syndrome Background: Sjogren's syndrome (SS) may be associated with various pathologies of the central nervous system. It…
  • 2023 International Congress

    Effects of intermittent theta burst stimulation over primary motor cortex on functional connectivity in Parkinson’s disease patients

    G. Kotsoev, E. Fedotova, E. Kremneva, I. Bakulin, A. Poydasheva, N. Suponeva (Moscow, Russian Federation)

    Objective: To explore functional effect of intermittent theta burst stimulation (iTBS) protocol over primary motor cortex (M1) in Parkinson’s disease (PD) patients. Background: PD is…
  • 2023 International Congress

    Reliability of brainsense technology as compared to SoC in STN DBS programming

    I. Avilés-Olmos, L. Gonzalez-Quarante, A. Arcadi, P. Clavero, MC. Rodriguez-Oroz, M. Valencia, M. Alegre (Pamplona, Spain)

    Objective: We aimed to study coincidence between the contact selected at programming session by experienced neurologists at 6months follow up after bilateral STN DBS (considered…
  • 2023 International Congress

    Sex-Specific Association Between Plasma Vitamin D and Parkinson’s Disease: A Mendelian Randomization Study

    T. Antar, H. Iwaki (Bethesda, USA)

    Objective: To investigate whether there is a sex-specific causal relationship between plasma vitamin D levels and the risk of Parkinson's disease (PD). Background: Prior studies…
  • 2023 International Congress

    A retrospective comparison of functional and quality of life outcomes in DBS patients implanted via awake or asleep surgery: the Rush University Medical Center experience

    C. Swan, J. Mazza, V. Palakuzhy, M. Wedding, S. Ramos, N. Patel, S. Sani (Chicago, USA)

    Objective: We retrospectively compared quality of life and functional status metrics to assess differences among patients who underwent implantation of Deep Brain Stimulation (DBS) for…
  • 2023 International Congress

    The comparison of vaccination rate, health impact, and confidence of COVID-19 vaccines between patients with Parkinson’s disease and healthy population: evidence from a large multicenter survey in China

    C. Han, Z. Zhao, J. Ma (Beijing, China)

    Objective: To compare the coverage and influencing factors, security, and confidence of COVID-19 vaccination between patients with Parkinson’s disease (PD) and healthy individuals so as…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Kratom withdrawal induced orobuccal dyskinesia
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley